Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

KRX/008930 stock hub

KRX/008930 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/008930is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.5T

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/008930

In the news

Latest news · KRX/008930

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/E21.2

P25 12P50 23.1P75 39.5

ROE13

P25 -17.1P50 0.7P75 8.5

ROIC4.8

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/008930 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

242

Groups with data

Currency

KRW

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	476
Enterprise value	KRW 2.6T
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Medical Distribution
Isin	KR7008930000
Last refreshed	2026-05-10
Market cap	KRW 2.5T
Price	KRW 37,100
Price currency	KRW
Rev Per Employee	2,850,751,119.41x
Sector	Healthcare
Sic	5122
Symbol	krx/008930
Website	https://www.hanmiscience.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.71%
EV Earnings	21.93x
EV/EBIT	18.71x
EV/EBITDA	17.52x
EV/FCF	90.35x
EV/Sales	1.91x
FCF yield	1.14%
P/B ratio	2.62x
P/E ratio	21.24x
P/S ratio	1.85x
PE Ratio10 Y	106.77x
PE Ratio3 Y	28.1x
PE Ratio5 Y	49.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.2%
EBITDA Margin	4.9%
FCF margin	2.12%
Gross margin	22.94%
Gross Profit	KRW 311.3B
Gross Profit Growth	16.04%
Gross Profit Growth Q	96.59%
Gross Profit Growth3 Y	24.92%
Gross Profit Growth5 Y	21.21%
Net Income	KRW 118.4B
Net Income Growth	99.2%
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Net Income Growth3 Y	19.59%
Net Income Growth5 Y	39.26%
Pretax Margin	9.8%
Profit Margin	8.72%
Profit Per Employee	KRW 248.7M
Profitable Years	14
ROA	2.51
Roa5y	2.21
ROCE	5.66
ROE	13.02
Roe5y	10.24
ROIC	4.8
Roic5y	4.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-10.03%
Cagr15y	15.38%
Cagr1y	31.22%
Cagr20y	6.11%
Cagr3y	-4.1%
Cagr5y	-10.68%
Div CAGR10	-3.19%
Div CAGR3	14.47%
Div CAGR5	9.31%
EPS Growth	98.98
EPS Growth Quarters	4
EPS Growth Years	1
EPS Growth3 Y	20.02
EPS Growth5 Y	39.62
FCF Growth	-60.73%
FCF Growth Q	-84.99%
FCF Growth3 Y	140.94%
FCF Growth5 Y	17.44%
OCF Growth	-42.57%
OCF Growth Q	-71.66%
OCF Growth10 Y	0.15%
OCF Growth3 Y	71.48%
OCF Growth5 Y	28.1%
Revenue Growth	5.73x
Revenue Growth Q	5.17x
Revenue Growth Quarters	5x
Revenue Growth Years	8x
Revenue Growth3 Y	9.06x
Revenue Growth5 Y	9.62x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.96
Assets	KRW 1.5T
Cash	KRW 128.2B
Current Assets	KRW 386.2B
Current Liabilities	KRW 482.1B
Debt	KRW 214.5B
Debt EBITDA	KRW 3.23
Debt Equity	KRW 0.22
Debt FCF	KRW 7.47
Equity	KRW 959.2B
Interest Coverage	5.39
Liabilities	KRW 529.9B
Long Term Assets	KRW 1.1T
Long Term Liabilities	KRW 47.8B
Net Cash	KRW -86.4B
Net Cash By Market Cap	KRW -3.44
Net Debt EBITDA	KRW 1.3
Net Debt Equity	KRW 0.09
Net Debt FCF	KRW 3.01
Tangible Book Value	KRW 946.1B
Tangible Book Value Per Share	KRW 13,969
WACC	7.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.8
Inventory Turnover	9.04
Net Working Capital	KRW -10.1B
Quick ratio	0.48
Working Capital	KRW -95.9B
Working Capital Turnover	KRW -11.96

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.12%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	KRW 300
Dividend Years	1
Dividend Yield	0.81%
Ex Div Date	2026-03-30
Last Dividend	KRW 300
Payout Frequency	Annual
Payout Ratio	11.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-65.24%
1Y total return	31.2%
200-day SMA	40,088
3Y total return	-11.81%
50-day SMA	38,566
50-day SMA vs 200-day SMA	50under200
5Y total return	-43.14%
All Time High	177,364.3
All Time High Change	-79.08%
All Time High Date	2015-11-09
All Time Low	443.2
All Time Low Change	8,271.51%
All Time Low Date	1992-10-30
ATR	1,170.4
Beta	0.62
Beta1y	0.81
Beta2y	0.57
Ch YTD	2.35
High	37,450
High52	55,500
High52 Date	2026-02-24
High52ch	-33.15%
Low	36,550
Low52	28,350
Low52 Date	2025-05-08
Low52ch	32.98%
Ma50ch	-3.8%
Price vs 200-day SMA	-7.45%
RSI	41.83
RSI Monthly	49.23
RSI Weekly	45.38
Sharpe ratio	0.71x
Sortino ratio	1.22
Total Return	0.69%
Tr YTD	3.15
Tr15y	754.5%
Tr1m	-2.37%
Tr1w	-2.5%
Tr3m	-19.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 57B
Operating Income Growth	50.07
Operating Income Growth3 Y	26.54
Operating Income Growth5 Y	17.76
Operating margin	4.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	23,506,010%
Net Borrowing	-3,537,216,460
Shares Insiders	48.25%
Shares Institutions	15.04%
Shares Out	67,713,706
Shares Qo Q	0.25%
Shares Yo Y	0.12%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 28.5B
Average Volume	92,315.95x
Bv Per Share	14,201.6
CAPEX	KRW -18.9B
Ch10y	-66.76
Ch15y	713.9
Ch1m	-2.37
Ch1w	-2.5
Ch1y	30.18
Ch20y	206.2
Ch3m	-20.13
Ch3y	-13.82
Ch5y	-44.94
Ch6m	-4.87
Change	1.37%
Change From Open	0.68
Close	36,600
Days Gap	0.68
Depreciation Amortization	9,481,021,950
Dollar Volume	2,913,388,800
Earnings Date	2026-04-30
EBIT	KRW 57B
EBITDA	KRW 66.4B
EPS	KRW 1,747
F Score	5
FCF	KRW 28.7B
FCF EV Yield	1.11x
FCF Per Share	KRW 424
Financing CF	-17,079,957,660
Fiscal Year End	December
Founded	1,973
Graham Number	23626.90224
Graham Upside	-36.32
Income Tax	KRW 15.3B
Investing CF	12,209,519,760
Is Primary Listing	1
Last Earnings Date	2026-04-30
Last Report Date	2025-12-31
Last Split Date	2022-12-28
Last Split Type	Forward
Lynch Fair Value	KRW 43,675
Lynch Upside	17.72
Ma150	38,984.3
Ma150ch	-4.83%
Ma20	38,592.5
Ma20ch	-3.87%
Net CF	42,160,890,460
Next Earnings Date	2026-08-14
Open	36,850
P FCF Ratio	87.44
P OCF Ratio	52.71
Payment Date	2026-04-17
Position In Range	61.11
Ppne	108,514,066,990
Price Date	2026-05-08
Price EBITDA	KRW 37.81
Ptbv Ratio	2.66
Relative Volume	0.82x
Revenue	1,356,957,532,840x
SBC By Revenue	0.02x
Share Based Comp	211,210,410
Tax By Revenue	1.13x
Tax Rate	11.5%
Tr20y	227.52%
Tr6m	-4.12%
Volume	78,528
Z Score	4.44

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/008930 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.8%

$300 annual per share

Payout ratio

+11.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+9.3%

1 consecutive years of growth

Total shareholder yield

+0.7%

Next ex-dividend date: 2026-03-30

Performance

KRX/008930 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/008930?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.0%

Share of float held by funds and institutions

Insider ownership

+48.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

KRX/008930 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.8

Neutral momentum band

Price vs 200-day MA

-7.5%

50/200-day relationship not available

Beta (5Y)

0.62

Less volatile than the market

Sharpe ratio

0.71

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/008930

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/008930 stock rating?

krx/008930 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/008930 analysis?

The full report lives at /stocks/krx/008930/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/008930?

The latest report frames krx/008930 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/008930 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.